Druggable phosphatases in cancer and immune cells, with examples of their corresponding drugs. Structures of allosteric inhibitors targeting PP2A, PRL3, DUSP1/6, and SHP2 in cancer cells (left).

A team from the Research Institute of the McGill University Health Center (The Institute), led by Jean-Jacques Lebrun, Ph.D., ...

Colorectal tumors that underwent somatic next-generation sequencing (NGS) for 154-168 genes in an in-house laboratory between 2015 and 2022 were retrospectively identified. Microsatellite instability ...

A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of ...

Scientists suggest findings highlight potential targets and could lead to the development of therapies that specifically block the tumor’s ability to spread.

JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...

A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of ...